M&A Deal Summary

HiRO Acquires Courante Oncology

On August 31, 2023, HiRO acquired life science company Courante Oncology

Acquisition Highlights
  • This is HiRO’s 1st transaction in the Life Science sector.
  • This is HiRO’s 1st transaction in the United States.
  • This is HiRO’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2023-08-31
Target Courante Oncology
Sector Life Science
Buyer(s) HiRO
Deal Type Add-on Acquisition
Advisor(s) Generational Equity LLC (Financial)

Target

Courante Oncology

Excelsior, Minnesota, United States
Courante Oncology is a full-service clinical research provider specializing in oncology product development. The company offers a wide range of clinical trial management and support services to the pharmaceutical and medical device industries, including project management, clinical site monitoring, quality assurance, and medical writing services. Courante Oncology was founded in 1999 and is based in Excelsior, Minnesota.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

HiRO

Shanghai, China
Category Company
Founded 2020
Sector Life Science
DESCRIPTION

HiRO is a clinical research organization (CRO). With global operations and integration capabilities, HiRO provides a full range of cross-border solutions and services to its clients, including early pre-clinical strategic planning, clinical trial design, regulatory, pharmacovigilance, statistics, data management, end-to-end project management, and clinical and medical monitoring services. HiRO was founded in 2020 and is based in Shanghai, China.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (Minnesota) 1 of 1
Country (United States) 1 of 2
Year (2023) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-01 DeltaMed Solutions

Somerset, New Jersey, United States

DeltaMed Solutions is a global life sciences CRO that excels in building strategic partnerships with pharmaceutical companies, biotechnology firms, and CROs. The company leverages its extensive expertise and experience to accelerate the market entry of innovative therapies, significantly reducing time and cost. DeltaMed Solutions is based in Somerset, New Jersey.

Buy -
Mergr

Product

Company

Legal